Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pudilan Keyanning mouthrinse for dental plaque and gingivitis
ChiCTR2000041253Phase 4Recruiting
- Sponsor
- Peking University School of Stomatology
- Start
- Jan 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Pudilan Keyanning mouthrinse in gingivitis (3 arms), sponsored by Peking University School of Stomatology. Primary endpoints: Plaque Index (modified Quigley-Hein), Gingiva Index and 2 more. Started Jan 2020; status: recruiting.
02
Drugs
Pudilan Keyanning mouthrinse
03
Conditions
gingivitis
Beyond the preview
Go deeper on ChiCTR2000041253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041253.